BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24970802)

  • 1. Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4/6-mediated survival signals.
    Kumar S; Raina K; Agarwal C; Agarwal R
    Oncotarget; 2014 Jul; 5(13):4972-89. PubMed ID: 24970802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin.
    Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Segura-Carretero A; Joven J; Martin-Castillo B; Barrajón-Catalán E; Micol V; Bosch-Barrera J; Menendez JA
    Cell Cycle; 2013 Nov; 12(21):3390-404. PubMed ID: 24047698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silibinin suppresses the maintenance of colorectal cancer stem-like cells by inhibiting PP2A/AKT/mTOR pathways.
    Wang JY; Chang CC; Chiang CC; Chen WM; Hung SC
    J Cell Biochem; 2012 May; 113(5):1733-43. PubMed ID: 22213051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.
    Kaur M; Velmurugan B; Tyagi A; Agarwal C; Singh RP; Agarwal R
    Neoplasia; 2010 May; 12(5):415-24. PubMed ID: 20454513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway.
    Momeny M; Ghasemi R; Valenti G; Miranda M; Zekri A; Zarrinrad G; Javadikooshesh S; Yaghmaie M; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Tumour Biol; 2016 Mar; 37(3):3913-23. PubMed ID: 26482609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF Signalling in the Self-Renewal of Colon Cancer Organoids.
    Otte J; Dizdar L; Behrens B; Goering W; Knoefel WT; Wruck W; Stoecklein NH; Adjaye J
    Sci Rep; 2019 Nov; 9(1):17365. PubMed ID: 31758153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells.
    Rugamba A; Kang DY; Sp N; Jo ES; Lee JM; Bae SW; Jang KJ
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin affects tumor cell growth because of reduction of stemness properties and induction of apoptosis in 2D and 3D models of MDA-MB-468.
    Abdollahi P; Ebrahimi M; Motamed N; Samani FS
    Anticancer Drugs; 2015 Jun; 26(5):487-97. PubMed ID: 25603020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells.
    Bhatia V; Falzon M
    Cancer Lett; 2015 Jul; 362(2):199-207. PubMed ID: 25846868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice.
    Ravichandran K; Velmurugan B; Gu M; Singh RP; Agarwal R
    Clin Cancer Res; 2010 Sep; 16(18):4595-606. PubMed ID: 20823143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of silibinin in human colorectal cancer cells: targeting the activation of NF-κB signaling.
    Raina K; Agarwal C; Agarwal R
    Mol Carcinog; 2013 Mar; 52(3):195-206. PubMed ID: 22086675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation.
    Boothello RS; Patel NJ; Sharon C; Abdelfadiel EI; Morla S; Brophy DF; Lippman HR; Desai UR; Patel BB
    Mol Cancer Ther; 2019 Jan; 18(1):51-61. PubMed ID: 30337351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silibinin inhibits translation initiation: implications for anticancer therapy.
    Lin CJ; Sukarieh R; Pelletier J
    Mol Cancer Ther; 2009 Jun; 8(6):1606-12. PubMed ID: 19509268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
    Deep G; Kumar R; Jain AK; Agarwal C; Agarwal R
    Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heparan sulfate proteoglycan syndecan-1 regulates colon cancer stem cell function via a focal adhesion kinase-Wnt signaling axis.
    Kumar Katakam S; Tria V; Sim WC; Yip GW; Molgora S; Karnavas T; Elghonaimy EA; Pelucchi P; Piscitelli E; Ibrahim SA; Zucchi I; Reinbold R; Greve B; Götte M
    FEBS J; 2021 Jan; 288(2):486-506. PubMed ID: 32367652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
    Yu Y; Nangia-Makker P; Farhana L; G Rajendra S; Levi E; Majumdar AP
    Mol Cancer; 2015 May; 14():98. PubMed ID: 25928322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation.
    Li Y; Wang L; Pappan L; Galliher-Beckley A; Shi J
    Mol Cancer; 2012 Nov; 11():87. PubMed ID: 23174018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
    Hwang WL; Yang MH; Tsai ML; Lan HY; Su SH; Chang SC; Teng HW; Yang SH; Lan YT; Chiou SH; Wang HW
    Gastroenterology; 2011 Jul; 141(1):279-91, 291.e1-5. PubMed ID: 21640118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
    Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
    Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silibinin down-regulates expression of secreted phospholipase A2 enzymes in cancer cells.
    Hagelgans A; Nacke B; Zamaraeva M; Siegert G; Menschikowski M
    Anticancer Res; 2014 Apr; 34(4):1723-9. PubMed ID: 24692702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.